Cessation of imatinib mesylate may lead to sustained hematologic and molecular remission in FIP1L1-PDGFRA-mutated hypereosinophilic syndrome.
about
How I treat hypereosinophilic syndromes.Long-term outcomes of imatinib in patients with FIP1L1/ PDGFRA associated chronic eosinophilic leukemia: experience of a single center in China.Clinical features predict responsiveness to imatinib in platelet-derived growth factor receptor-alpha-negative hypereosinophilic syndrome.World Health Organization-defined eosinophilic disorders: 2017 update on diagnosis, risk stratification, and management.Imatinib Treatment in PDGFRA-Negative Childhood Hypereosinophilic Syndrome.Imatinib discontinuation for hypereosinophilic syndrome harboring the FIP1L1-PDGFRA transcript.Diagnosis and Novel Approaches to the Treatment of Hypereosinophilic Syndromes.Long-term therapy-free remission in a patient with platelet-derived growth factor receptor beta-rearranged myeloproliferative neoplasm.
P2860
Q36000858-B7A88C80-DD59-453D-A094-4C12EDC20FE1Q37362888-1E6906B9-89F4-4527-9A2F-C237CFBD47A2Q40822125-99D4A7F4-112F-4A49-A6A4-B82B25F7C981Q46026437-57CDFB22-858D-4357-8048-18C5385B4E6EQ50996871-89859BC8-4817-48C1-8F41-85380BEC5D01Q52912578-CB8F9F00-ADE9-4AD4-8F44-34B1498043F5Q54114931-BD360115-36E1-43CD-AD9E-D97A59E4BF58Q55022456-2637E8A0-50A9-4EAF-8064-8641B9A21068
P2860
Cessation of imatinib mesylate may lead to sustained hematologic and molecular remission in FIP1L1-PDGFRA-mutated hypereosinophilic syndrome.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh-hant
name
Cessation of imatinib mesylate ...... ed hypereosinophilic syndrome.
@en
Cessation of imatinib mesylate ...... ed hypereosinophilic syndrome.
@nl
type
label
Cessation of imatinib mesylate ...... ed hypereosinophilic syndrome.
@en
Cessation of imatinib mesylate ...... ed hypereosinophilic syndrome.
@nl
prefLabel
Cessation of imatinib mesylate ...... ed hypereosinophilic syndrome.
@en
Cessation of imatinib mesylate ...... ed hypereosinophilic syndrome.
@nl
P2860
P356
P1476
Cessation of imatinib mesylate ...... ed hypereosinophilic syndrome.
@en
P2093
Sławomira Kyrcz-Krzemień
P2860
P356
10.1002/AJH.23588
P577
2013-10-15T00:00:00Z